Skip to content
OpenCapital
Get started

Co-Diagnostics, Inc. CODX Q4 2025 Annual earnings

Reported March 31, 2026

Revenue$262.5KBeat by $136.6KDiluted EPS-$16.35Miss by $12.75
Revenue estimate$125.9K
EPS estimate-$3.60

Next report

Aug 14, 2026 (in a month)
Revenue estimate$132.6K
EPS estimate-$3.00

Versus estimates

Revenue

Q1 2026$146.0KBeat by $18.9K
Q4 2025$262.5KBeat by $136.6K
Q3 2025$145.4KBeat by $19.4KQ2 2025$162.9KMiss by $137.1KQ1 2025$50.3KMiss by $137.2KQ4 2024$149.3KMiss by $225.7K

Diluted EPS

Q1 2026-$4.06Miss by $0.31
Q4 2025-$16.35Miss by $12.75
Q3 2025-$4.80Beat by $0.91Q2 2025-$0.23Beat by $0.02Q1 2025-$0.24Beat by $0.09Q4 2024-$0.36Miss by $0.02

Ask the moment Co-Diagnostics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Co-Diagnostics, Inc. report Q4 2025 earnings?
Co-Diagnostics, Inc. (CODX) reported Q4 2025 earnings on March 31, 2026.
What were Co-Diagnostics, Inc. 's Q4 2025 revenue and EPS?
Co-Diagnostics, Inc. reported revenue of $262.5K and diluted EPS of $-16.35 for Q4 2025.
Did Co-Diagnostics, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $125.9K by $136.6K. EPS missed the consensus estimate of $-3.60 by $12.75.
How did Co-Diagnostics, Inc. 's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 75.8% from $149.3K a year earlier and diluted EPS declined 4441.7% from $-0.36.
Where can I find Co-Diagnostics, Inc. 's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001493152-26-014129) and the 10-K periodic report (0001493152-26-014158) directly on SEC EDGAR. The filing index links above go to sec.gov.